Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

BACKGROUND: Immune checkpoint inhibitors (ICI) produce durable antitumor responses but provoke autoimmune toxicities, including uncommon but potentially devastating neurologic toxicities. The clinical features, including the spectrum, timing, and outcomes, of ICI-induced neurologic toxicities are no...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Douglas B., Manouchehri, Ali, Haugh, Alexandra M., Quach, Henry T., Balko, Justin M., Lebrun-Vignes, Benedicte, Mammen, Andrew, Moslehi, Javid J., Salem, Joe-Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530194/
https://www.ncbi.nlm.nih.gov/pubmed/31118078
http://dx.doi.org/10.1186/s40425-019-0617-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530194/
https://www.ncbi.nlm.nih.gov/pubmed/31118078
http://dx.doi.org/10.1186/s40425-019-0617-x

Ejemplares similares